|
ZFYVE9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.22044604925031E-16 |
| Normal-vs-Stage3 |
1.38777878078145E-14 |
| Normal-vs-Stage4 |
2.75224287804576E-13 |
| Stage1-vs-Stage2 |
8.771800E-01 |
| Stage1-vs-Stage3 |
3.444000E-01 |
| Stage1-vs-Stage4 |
7.699800E-01 |
| Stage2-vs-Stage3 |
3.754400E-01 |
| Stage2-vs-Stage4 |
8.398400E-01 |
| Stage3-vs-Stage4 |
3.740000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
4.79770000394453E-08 |
| Caucasian-vs-AfricanAmerican |
1.549600E-01 |
| Caucasian-vs-Asian |
5.228800E-01 |
| AfricanAmerican-vs-Asian |
9.883800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
3.574918139293E-14 |
| Male-vs-Female |
7.52589999986064E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.67188485278302E-12 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
<1E-12 |
| Normal-vs-Extreme_Obese |
6.49790221629587E-11 |
| Normal_Weight-vs-Extreme_Weight |
3.789600E-02 |
| Normal_Weight-vs-Obese |
4.870400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.717000E-01 |
| Extreme_Weight-vs-Obese |
2.644200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.333600E-01 |
| Obese-vs-Extreme_Obese |
7.468200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.92129645526506E-11 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.04281036531029E-14 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.277000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.518210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.073200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.562600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.375600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.228200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
6.15440000073519E-08 |
| Normal-VS-Unclassified PRCC |
1.62447832963153E-12 |
| Type1 PRCC-VS-Type2 PRCC |
6.868300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.124250E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.767160E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.757400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.536600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.653020E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.87245790989255E-13 |
| Normal-vs-N2 |
1.5059000000317E-06 |
| N0-vs-N1 |
6.107700E-02 |
| N0-vs-N2 |
4.128200E-01 |
| N1-vs-N2 |
8.897000E-01 |
|
|
